Hyperphosphatemia in multiple myeloma.
Cheikhrouhou Abdelmoula
Leila
L
Amira
Chiraz
C
Chaabouni
Lilia
L
Kchir
Mohamed Montacer
MM
Zouari
Rafik
R
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000150:complications*; D010710:Phosphates / Q000097:blood; D010760:Phosphorus Metabolism Disorders / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D018906:Antineoplastic Agents, Alkylating; D010710:Phosphates